Verp M - Search Results

1

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers.

Bradbury AR, Ibe CN, Dignam JJ, Cummings SA, Verp M, White MA, Artioli G, Dudlicek L, Olopade OI. Bradbury AR, et al. Among authors: verp m. Genet Med. 2008 Mar;10(3):161-166. doi: 10.1097/GIM.0b013e318163487d. Genet Med. 2008. PMID: 18344704 Free PMC article.

2

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.

Guindalini RSC, Zheng Y, Abe H, Whitaker K, Yoshimatsu TF, Walsh T, Schacht D, Kulkarni K, Sheth D, Verp MS, Bradbury AR, Churpek J, Obeid E, Mueller J, Khramtsova G, Liu F, Raoul A, Cao H, Romero IL, Hong S, Livingston R, Jaskowiak N, Wang X, Debiasi M, Pritchard CC, King MC, Karczmar G, Newstead GM, Huo D, Olopade OI. Guindalini RSC, et al. Among authors: verp ms. Clin Cancer Res. 2019 Mar 15;25(6):1786-1794. doi: 10.1158/1078-0432.CCR-18-0200. Epub 2018 Aug 28. Clin Cancer Res. 2019. PMID: 30154229 Free PMC article.

3

Breast cancer detected on an incident (second or subsequent) round of screening MRI: MRI features of false-negative cases.

Yamaguchi K, Schacht D, Newstead GM, Bradbury AR, Verp MS, Olopade OI, Abe H. Yamaguchi K, et al. Among authors: verp ms. AJR Am J Roentgenol. 2013 Nov;201(5):1155-63. doi: 10.2214/AJR.12.9707. AJR Am J Roentgenol. 2013. PMID: 24147491

4

Utilization of Complementary Alternative Medicine, Diet, and Exercise Among Women at High Risk for Developing Breast Cancer.

Lee RT, Amico A, Malaka D, Lewin R, Cummings SA, Verp M, Patrick-Miller L, Bradbury AR, Olopade OI. Lee RT, et al. Among authors: verp m. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420922610. doi: 10.1177/1534735420922610. Integr Cancer Ther. 2020. PMID: 32448019 Free PMC article.

5

Use of decision analysis to evaluate patients' choices of diagnostic prenatal test.

Verp MS, Heckerling PS. Verp MS, et al. Am J Med Genet. 1995 Sep 25;58(4):337-44. doi: 10.1002/ajmg.1320580407. Am J Med Genet. 1995. PMID: 8533842

6

Parental decision following prenatal diagnosis of fetal chromosome abnormality.

Verp MS, Bombard AT, Simpson JL, Elias S. Verp MS, et al. Am J Med Genet. 1988 Mar;29(3):613-22. doi: 10.1002/ajmg.1320290320. Am J Med Genet. 1988. PMID: 3377004

7

Cystic hygroma and 45,X/46,XY mosaicism.

Verp MS, Sheikh Z, Amarose AP, Cibils LA. Verp MS, et al. Am J Med Genet. 1989 Jul;33(3):402-4. doi: 10.1002/ajmg.1320330323. Am J Med Genet. 1989. PMID: 2679092

8

Growth disadvantage of 45,X and 46,X,del(X)(p11) fibroblasts.

Verp MS, Rosinsky B, Le Beau MM, Martin AO, Kaplan R, Wallemark CB, Otano L, Simpson JL. Verp MS, et al. Clin Genet. 1988 Apr;33(4):277-85. doi: 10.1111/j.1399-0004.1988.tb03449.x. Clin Genet. 1988. PMID: 3359684

9

Patient or physician preferences for decision analysis: the prenatal genetic testing decision.

Heckerling PS, Verp MS, Albert N. Heckerling PS, et al. Among authors: verp ms. Med Decis Making. 1999 Jan-Mar;19(1):66-77. doi: 10.1177/0272989X9901900109. Med Decis Making. 1999. PMID: 9917022

10

A cost-effectiveness analysis of amniocentesis and chorionic villus sampling for prenatal genetic testing.

Heckerling PS, Verp MS. Heckerling PS, et al. Among authors: verp ms. Med Care. 1994 Aug;32(8):863-80. doi: 10.1097/00005650-199408000-00008. Med Care. 1994. PMID: 8057700

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters